{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T00:54:43Z","timestamp":1760576083066,"version":"build-2065373602"},"reference-count":29,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmcd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1016\/j.numecd.2015.05.008","type":"journal-article","created":{"date-parts":[[2015,6,13]],"date-time":"2015-06-13T19:45:08Z","timestamp":1434224708000},"page":"875-880","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["FABP4 plasma concentrations are determined by acquired metabolic derangements rather than genetic determinants"],"prefix":"10.1016","volume":"25","author":[{"given":"D.","family":"Ibarretxe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Girona","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Plana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Cabr\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Heras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Ferr\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Merino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.C.","family":"Vallv\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0789-4954","authenticated-orcid":false,"given":"L.","family":"Masana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.numecd.2015.05.008_bib1","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s00125-012-2737-4","article-title":"Adipocyte fatty acid binding protein: a novel adipokine involved in the pathogenesis of metabolic and vascular disease?","volume":"56","author":"Kralisch","year":"2013","journal-title":"Diabetologia"},{"key":"10.1016\/j.numecd.2015.05.008_bib2","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0952-3278(95)90010-1","article-title":"Fatty acids in cell signalling: modulation by lipid binding proteins","volume":"52","author":"Glatz","year":"1995","journal-title":"Prostagl Leukot Essent Fat Acids"},{"key":"10.1016\/j.numecd.2015.05.008_bib3","doi-asserted-by":"crossref","first-page":"935","DOI":"10.3109\/09513590.2011.569608","article-title":"Fatty acid-binding protein-4 plasma levels are associated to metabolic abnormalities and response to therapy in girls and young women with androgen excess","volume":"27","author":"Lazaro","year":"2011","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.numecd.2015.05.008_bib4","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1146\/annurev.nutr.17.1.277","article-title":"Intracellular lipid-binding proteins and their genes","volume":"17","author":"Bernlohr","year":"1997","journal-title":"Annu Rev Nutr"},{"key":"10.1016\/j.numecd.2015.05.008_bib5","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1161\/01.CIR.0000141735.13202.B6","article-title":"Combined adipocyte-macrophage fatty acid-binding protein deficiency improves metabolism, atherosclerosis, and survival in apolipoprotein E-deficient mice","volume":"110","author":"Boord","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.numecd.2015.05.008_bib6","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/89076","article-title":"Lack of macrophage fatty-acid-binding protein aP2 protects mice deficient in apolipoprotein E against atherosclerosis","volume":"7","author":"Makowski","year":"2001","journal-title":"Nat Med"},{"key":"10.1016\/j.numecd.2015.05.008_bib7","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1194\/jlr.M800102-JLR200","article-title":"Plasma fatty acid binding protein 4 is associated with atherogenic dyslipidemia in diabetes","volume":"49","author":"Cabre","year":"2008","journal-title":"J Lipid Res"},{"key":"10.1016\/j.numecd.2015.05.008_bib8","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.atherosclerosis.2010.07.026","article-title":"Fatty acid-binding protein 4 is associated with endothelial dysfunction in patients with type 2 diabetes","volume":"213","author":"Aragones","year":"2010","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.numecd.2015.05.008_bib9","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/j.amjcard.2010.06.028","article-title":"Relation of plasma fatty acid binding proteins 4 and 5 with the metabolic syndrome, inflammation and coronary calcium in patients with type-2 diabetes mellitus","volume":"106","author":"Bagheri","year":"2010","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.numecd.2015.05.008_bib10","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/1475-2840-11-72","article-title":"Fatty acid-binding protein 4 impairs the insulin-dependent nitric oxide pathway in vascular endothelial cells","volume":"11","author":"Aragones","year":"2012","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.numecd.2015.05.008_bib11","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1161\/CIRCRESAHA.109.200501","article-title":"Adipocyte fatty acid-binding protein suppresses cardiomyocyte contraction: a new link between obesity and heart disease","volume":"105","author":"Lamounier-Zepter","year":"2009","journal-title":"Circ Res"},{"key":"10.1016\/j.numecd.2015.05.008_bib12","doi-asserted-by":"crossref","first-page":"723","DOI":"10.2217\/bmm.13.61","article-title":"A-FABP and its association with atherogenic risk profile and insulin resistance in young overweight and obese women","volume":"7","author":"Mankowska-Cyl","year":"2013","journal-title":"Biomark Med"},{"key":"10.1016\/j.numecd.2015.05.008_bib13","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1476-511X-9-18","article-title":"Fatty-acid binding protein 4 gene variants and childhood obesity: potential implications for insulin sensitivity and CRP levels","volume":"9","author":"Khalyfa","year":"2010","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.numecd.2015.05.008_bib14","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1007\/s12020-009-9228-5","article-title":"FABP4: a novel candidate gene for polycystic ovary syndrome","volume":"36","author":"Wang","year":"2009","journal-title":"Endocrine"},{"key":"10.1016\/j.numecd.2015.05.008_bib15","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.sleep.2010.12.014","article-title":"Fatty-acid binding protein 4 gene polymorphisms and plasma levels in children with obstructive sleep apnea","volume":"12","author":"Bhushan","year":"2011","journal-title":"Sleep Med"},{"key":"10.1016\/j.numecd.2015.05.008_bib16","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.metabol.2003.10.010","article-title":"Genetic variation in fatty acid-binding protein-4 and peroxisome proliferator-activated receptor gamma interactively influence insulin sensitivity and body composition in males","volume":"53","author":"Damcott","year":"2004","journal-title":"Metabolism"},{"key":"10.1016\/j.numecd.2015.05.008_bib17","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1038\/oby.2009.496","article-title":"Common genetic variants in fatty acid-binding protein-4 (FABP4) and clinical diabetes risk in the Women's Health Initiative Observational Study","volume":"18","author":"Chan","year":"2010","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.numecd.2015.05.008_bib18","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/978-1-60327-411-1_20","article-title":"Qualitative and quantitative genotyping using single base primer extension coupled with matrix-assisted laser desorption\/ionization time-of-flight mass spectrometry (MassARRAY)","volume":"578","author":"Oeth","year":"2009","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.numecd.2015.05.008_bib19","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1007\/s11745-013-3838-7","article-title":"Common FABP4 genetic variants and plasma levels of fatty acid binding protein 4 in older adults","volume":"48","author":"Mukamal","year":"2013","journal-title":"Lipids"},{"key":"10.1016\/j.numecd.2015.05.008_bib20","doi-asserted-by":"crossref","first-page":"6970","DOI":"10.1073\/pnas.0602178103","article-title":"A genetic variant at the fatty acid-binding protein aP2 locus reduces the risk for hypertriglyceridemia, type 2 diabetes, and cardiovascular disease","volume":"103","author":"Tuncman","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.numecd.2015.05.008_bib21","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/j.1753-4887.2007.tb00290.x","article-title":"Identification of a functional polymorphism at the adipose fatty acid binding protein gene (FABP4) and demonstration of its association with cardiovascular disease: a path to follow","volume":"65","author":"Ordovas","year":"2007","journal-title":"Nutr Rev"},{"key":"10.1016\/j.numecd.2015.05.008_bib22","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1038\/ijo.2011.162","article-title":"Metabolic and genetic predictors of circulating adipocyte fatty acid-binding protein","volume":"36","author":"Tonjes","year":"2012","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/j.numecd.2015.05.008_bib23","doi-asserted-by":"crossref","first-page":"e31853","DOI":"10.1371\/journal.pone.0031853","article-title":"Common variants of the liver fatty acid binding protein gene influence the risk of type 2 diabetes and insulin resistance in Spanish population","volume":"7","author":"Mansego","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.numecd.2015.05.008_bib24","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.atherosclerosis.2012.02.003","article-title":"FABP4 predicts atherogenic dyslipidemia development. The PREDIMED study","volume":"222","author":"Cabre","year":"2012","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.numecd.2015.05.008_bib25","doi-asserted-by":"crossref","first-page":"e150","DOI":"10.1016\/j.atherosclerosis.2007.04.045","article-title":"Fatty acid binding protein 4 is increased in metabolic syndrome and with thiazolidinedione treatment in diabetic patients","volume":"195","author":"Cabre","year":"2007","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.numecd.2015.05.008_bib26","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1007\/s11745-012-3689-7","article-title":"Plasma levels of FABP4, but not FABP3, are associated with increased risk of diabetes","volume":"47","author":"Djousse","year":"2012","journal-title":"Lipids"},{"key":"10.1016\/j.numecd.2015.05.008_bib27","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1002\/oby.20954","article-title":"FABP4 is secreted from adipocytes by adenyl cyclase-PKA- and guanylyl cyclase-PKG-dependent lipolytic mechanisms","volume":"23","author":"Mita","year":"2015","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.numecd.2015.05.008_bib28","doi-asserted-by":"crossref","first-page":"e81914","DOI":"10.1371\/journal.pone.0081914","article-title":"FABP4 induces vascular smooth muscle cell proliferation and migration through a MAPK-dependent pathway","volume":"8","author":"Girona","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.numecd.2015.05.008_bib29","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/1475-2840-12-72","article-title":"Parallel evolution of circulating FABP4 and NT-proBNP in heart failure patients","volume":"12","author":"Cabre","year":"2013","journal-title":"Cardiovasc Diabetol"}],"container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939475315001325?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939475315001325?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T16:09:28Z","timestamp":1760544568000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939475315001325"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":29,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["S0939475315001325"],"URL":"https:\/\/doi.org\/10.1016\/j.numecd.2015.05.008","relation":{},"ISSN":["0939-4753"],"issn-type":[{"type":"print","value":"0939-4753"}],"subject":[],"published":{"date-parts":[[2015,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"FABP4 plasma concentrations are determined by acquired metabolic derangements rather than genetic determinants","name":"articletitle","label":"Article Title"},{"value":"Nutrition, Metabolism and Cardiovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.numecd.2015.05.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}